Accreditation
The American Society of Health-System Pharmacists is accredited by the Accreditation Council for Pharmacy Education as a provider of continuing pharmacy education with Commendation.
The American College of Clinical Pharmacy is accredited by the Accreditation Council for Pharmacy Education as a provider of continuing pharmacy education.
These activities were presented as part of the 2023 ACCP Annual Meeting and 2023 ASHP Midyear Clinical Meeting. Learners who claimed ACPE credit for these activities as part of that meeting should not claim ACPE credit again.
Activity Overview
The Clinical Sessions Package is intended for board certified pharmacists in need of recertification credit and is designed based on the content outline developed by the Board of Pharmacy Specialties (BPS). Using a case-based approach, the activities provide high-level, interactive discussions on contemporary and emerging issues oncology.
The Oncology Clinical Sessions Recertification Package consists of 2 activities (see table below) and provides up to 4.0 contact hours of continuing pharmacy education and/or recertification credit.
These activities are part of the ASHP and ACCP professional development program for BCOP recertification approved by the BPS.
Target Audience
These recertification activities are intended for board certified pharmacists seeking to update their knowledge and skills in:
- Management of diffuse large B-cell lymphoma
- Management of amyloidosis
Recertification Credit*
Board certified pharmacists are eligible to receive up to 4.0 contact hours of recertification credit for completing this course. To earn recertification credit, learners must review the course content and successfully complete the online assessments by the deadline.
ASHP provides an opportunity for remediatrion. Participants who are unsuccessful with the first assessment attempt may take a second assessment. The second assessment is included at no additional cost.
ACCP and ASHP are approved by BPS as a provider for the recertification of BCOP.
|
Learning Activity |
ACPE Number |
Contact Hours |
Specialty |
Recertification Assessment |
|
Emerging Therapies and Clinical Controversies in the Management of Diffuse Large B-Cell Lymphoma |
0217-9999-23-075-H01-P |
2.0 ACPE |
BCOP |
81% |
|
Amyloidosis: Updates and Clinical Management |
0217-9999-23-076-H01-P |
2.0 ACPE |
BCOP |
85% |
|
Total Contact Hours |
4.0 BPS |
|
|
System Technical Requirements
Learning activities are delivered via your Web browser and Acrobat PDF. For all activities, you should have a basic comfort level using a computer and navigating web sites.
View the minimum technical and system requirements for learning activities.
Development
ACCP and ASHP collaborate on oncology pharmacy activities.